Financing, Equity Capital Markets

Poseida Therapeutics, Inc.

08/22
|
$80.5 Million
Piper Sandler served as bookrunner for Poseida Therapeutics, Inc. on a follow on offering
Sub-Type
CMFO
Sub-Sector
Biopharma